Identification of 20(S)-protopanaxadiol metabolites in human plasma and urine using UPLC-Q-TOF

20(S)-Protopanaxadiol (PPD), the aglycone part of 20(S)-protopanaxadiol ginsenosides, possesses antidepressant activity among many other pharmacological activities. It is currently undergoing clinical trial in China as an antidepressant.